C. Jenkins

C. Jenkins, M. Partridge, H. Reddel, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Adherence to inhaled therapy, mortality and hospital admission in COPD

J A Anderson, P. Jones, P. Calverley, 2009, Thorax.

Salmeterol/Fluticasone propionate and survival in chronic obstructive pulmonary disease:the TORCH trail.

C. Jenkins, B. Celli, J. Vestbo, 2007 .

Implementing evidence into practice to improve chronic lung disease management in Indigenous Australians: the breathe easy, walk easy, lungs for life (BE WELL) project (protocol)

C. Jenkins, Kylie Gwynne, G. Maguire, 2022, BMC Pulmonary Medicine.

Quality of life, stage severity and COPD

C. Jenkins, R. Rodríguez-Roisín, 2009, European Respiratory Journal.

Optimal asthma control, starting with high doses of inhaled budesonide.

C. Jenkins, C. Salome, A. Woolcock, 2000, The European respiratory journal.

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.

C. Jenkins, B. Lundbäck, B. Lundback, 2000, Respiratory medicine.

Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies

C. Jenkins, 2019, Therapeutics and clinical risk management.

The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma

C. Jenkins, A. James, G. Marks, 2020, European Respiratory Journal.

Starting steroids for asthma

C. Jenkins, 2006 .

Correspondence in relation to critical appraisal by Chapman et al

C. Jenkins, M. Peters, 2010, Thorax.

An update on asthma management

C. Jenkins, 2003, Internal medicine journal.

Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma

C. Jenkins, E. Juniper, M. Price, 2002, American journal of respiratory medicine : drugs, devices, and other interventions.

7. Asthma in adults

C. Jenkins, A. Woolcock, 1997 .

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

C. Jenkins, S. Anderson, C. Salome, 2001, American journal of respiratory and critical care medicine.

Diagnosis and management of asthma, COPD and asthma‐COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey

D. Postma, F. Martinez, P. Calverley, 2019, The clinical respiratory journal.

Epilogue to contemporary perspectives in COPD: New Horizons

C. Jenkins, 2021, Respirology.

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.

C. Jenkins, P. Mullins, F. Blasi, 2001, American journal of respiratory and critical care medicine.

A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations.

C. Jenkins, C. Salome, A. Woolcock, 2002, Swiss medical weekly.

Differences Between Men and Women with Chronic Obstructive Pulmonary Disease.

C. Jenkins, 2021, Clinics in chest medicine.

Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.

C. Jenkins, S. Anderson, C. Salome, 2001, The European respiratory journal.

COPD_A_339889 273..282

C. Jenkins, N. Zhong, B. Celli, 2022 .

Asthma in Older Adults: a Holistic, Person-centred and Problem-oriented Approach

C. Jenkins, G. Marks, P. Gibson, 2022 .

Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma.

C. Jenkins, S. Anderson, J. D. du Toit, 1994, Chest.

Upper respiratory tract infections and airway reactivity in normal and asthmatic subjects.

C. Jenkins, A. Breslin, 1984, The American review of respiratory disease.

Corticosteroids in the Modulation of Bronchial Hyperresponsiveness

C. Jenkins, A. Woolcock, 1990, Immunology and Allergy Clinics of North America.

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma.

C. Jenkins, A. Rubinfeld, C. Mitchell, 2003, Pulmonary pharmacology & therapeutics.

Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μ g twice daily and budesonide 800 μ g twice daily in the treatment of adults and adolescents with asthma

C. Jenkins, B. Lundbäck, R. Thwaites, 2000 .

Asthma in Indigenous Australians: so much yet to do for Indigenous lung health

C. Jenkins, A. Chang, G. Marks, 2009, The Medical journal of Australia.

Too little, too late? The underuse of beta‐blockers in COPD needs evidence to address clinical uncertainty

C. Jenkins, 2020, Respirology.

A new perspective on optimal care for patients with COPD.

D. Postma, B. Make, C. Jenkins, 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

Distinguishing asthma and chronic obstructive pulmonary disease: why, why not and how?

R. Wood‐Baker, C. Jenkins, P. Thompson, 2005, The Medical journal of Australia.

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

D. Postma, B. Make, C. Jenkins, 2017, International journal of chronic obstructive pulmonary disease.

More Action to Address the Impact of Smoking in Women.

C. Jenkins, 2017, American journal of respiratory and critical care medicine.

COPD

D. Mannino, A. Buist, C. Jenkins, 2018, Chest.

The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial

C. Jenkins, N. Zhong, B. Celli, 2020, European Respiratory Journal.

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

P. Calverley, C. Jenkins, B. Celli, 2008, American journal of respiratory and critical care medicine.

Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma.

C. Jenkins, F. Blasi, P. Black, 2000, The European respiratory journal.

Mars and Venus in the GP's office

C. Jenkins, 2006, European Respiratory Journal.

9. Chronic obstructive pulmonary disease

C. Jenkins, C. Mitchell, C. R. Jenkins, 1997 .

THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IMPROVES SURVIVAL IN COPD OVER THREE YEARS

C. Jenkins, N. Pride, B. Celli, 2006 .

Educational intervention for older people with asthma: a randomised controlled trial.

C. Jenkins, M. Crane, E. Paul, 2013, Patient education and counseling.

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

C. Jenkins, B. Celli, J. Vestbo, 2009, Respiratory research.

Formoterol as relief medication in asthma: the jury is still out

C. Jenkins, 2003, European Respiratory Journal.

Inhaled corticosteroid dosage in asthma

C. Jenkins, C. Salome, G. Marks, 2002, Thorax.

Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide.

C. Jenkins, S. Anderson, A. Woolcock, 1997, Allergy and asthma proceedings.

Effects of Ongoing Feedback During a 12-Month Maintenance Walking Program on Daily Physical Activity in People with COPD

C. Jenkins, J. Alison, Z. McKeough, 2019, Lung.

Dual bronchodilator treatment for prevention of COPD in at‐risk smokers

C. Jenkins, C. Farah, C. Thamrin, 2022, Respirology.

More than just reassurance on tiotropium safety.

C. Jenkins, 2013, The New England journal of medicine.

Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D

D. Postma, B. Make, C. Jenkins, 2015, European Respiratory Journal.

Complementary and alternative medicine use in asthma: Who is using what?

C. Jenkins, S. Bosnic-Anticevich, C. Armour, 2006, Respirology.

Sodium cromoglycate in asthma

C. Jenkins, H. Reddel, 2001, Thorax.

Improving paediatric asthma outcomes in primary health care: a randomised controlled trial

C. Jenkins, B. Toelle, T. Usherwood, 2011, Medical Journal of Australia.

Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma.

C. Jenkins, A. Woolcock, A. Woolcock, 1990, The Medical clinics of North America.

Salmeterol/Fluticasone Propionate Combination (SFC) Improves Survival in COPD over Three Years: On-Treatment Analysis from the TORCH Study.

C. Jenkins, B. Celli, J. Vestbo, 2009, ATS 2009.

Salmeterol/Fluticasone Propionate (SFC) Is Efficacious in GOLD Stage II COPD Patients: Analysis from the TORCH Study.

C. Jenkins, B. Celli, J. Vestbo, 2009, ATS 2009.

THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IS WELL TOLERATED IN PATIENTS WITH COPD OVER 3 YEARS

C. Jenkins, N. Pride, B. Celli, 2006 .

THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL IMPROVES AND SUSTAINS HEALTH STATUS IN COPD OVER 3 YEARS

C. Jenkins, N. Pride, B. Celli, 2006 .

THE TOWARDS A REVOLUTION IN COPD HEALTH (TORCH) STUDY: FLUTICASONE PROPIONATE/SALMETEROL REDUCES THE RATE OF EXACERBATIONS OVER 3 YEARS

C. Jenkins, N. Pride, B. Celli, 2006 .

Unmet Needs of Older People with Asthma: Cross-Sectional Survey

C. Jenkins, S. Bosnic-Anticevich, M. Crane, 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

‘Breathing Fire’: Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma

C. Jenkins, E. Holliday, P. Gibson, 2022, International journal of environmental research and public health.

Beta-2 agonists in asthma--the Thoracic Society of Australia and New Zealand.

C. Jenkins, J. Wilson, C. Robertson, 1995, Australian and New Zealand journal of medicine.

Is COPD in its age of enlightenment?

C. Jenkins, 2014, The Lancet. Respiratory medicine.

Peak flow meter use in asthma management

C. Jenkins, P. Sly, R. Ruffin, 1996 .

GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY

Christine Jenkins, R. Pauwels, A. Buist, 2001 .

Long‐acting ß2‐agonists: the new symptom controllers for asthma

C. Jenkins, C. R. Jenkins, 1999, The Medical journal of Australia.

Successes and challenges of COPD management in Australia: reflections on the past and future.

C. Jenkins, 2016, The Lancet. Respiratory medicine.

CHARACTERISATION OF SEVERE ASTHMA PHENOTYPES VIA A SEVERE ASTHMA REGISTRY: THE SEVERE ASTHMA WEB-BASED DATABASE

Smith, C. Jenkins, M. Hew, 2016 .

Intervention Educational intervention for older people with asthma : A randomised controlled trial

C. Jenkins, M. Crane, E. Paul, 2013 .

A score to predict short-term risk of COPD exacerbations (SCOPEX)

D. Postma, B. Make, C. Jenkins, 2015, International journal of chronic obstructive pulmonary disease.

Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

C. Jenkins, V. Jha, M. Jardine, 2021, Trials.

Adding formoterol is more effective and safer than doubling the dose of inhaled steriods in moderately severe asthma

C. Jenkins, A. Rubinfeld, C. Mitchell, 2000, ATS 2000.

Reply to "Importance of β2-receptor function in premenstrual asthma".

C. Jenkins, L. Boulet, C. Raherison-Semjen, 2022, The journal of allergy and clinical immunology. In practice.

Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β

C. Jenkins, A. James, S. Hodge, 2015, Respiratory Research.

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

P. Jones, P. Calverley, C. Jenkins, 2009, European Respiratory Journal.

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Bartolome Celli, Christine Jenkins, C. Jenkins, 2007, The New England journal of medicine.

Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma.

C. Jenkins, A. James, S. Wesselingh, 2019, American journal of respiratory and critical care medicine.

Clinical responses to corticosteroids

C. Jenkins, A. Woolcock, 1991 .

FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals

C. Jenkins, P. Kelly, T. Kotsimbos, 2011, The Medical journal of Australia.

Working while unwell: Workplace impairment in people with severe asthma

P. Gibson, C. Jenkins, M. Hew, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Aerosol and oral corticosteroids in the treatment of asthma.

C. Jenkins, A. Woolcock, 1988, Agents and actions. Supplements.

Spirometry performance in primary care: the problem, and possible solutions.

C. Jenkins, 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

P. Gibson, C. Jenkins, M. Hew, 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Addressing sex and gender to improve asthma management

C. Jenkins, L. Boulet, K. Lavoie, 2022, NPJ primary care respiratory medicine.

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study

C. Jenkins, G. Criner, J. Vestbo, 2021, Biomedicines.

Patient preferences for managing asthma: results from a discrete choice experiment.

C. Jenkins, J. Louviere, I. Hossain, 2007, Health economics.

Pulmonary cryptococcosis: atypical results in the serum test for cryptococcal antigen.

C. Jenkins, A. Breslin, 1982, Australian and New Zealand journal of medicine.

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2016, Clinical and Translational Allergy.

Integrated care pathways for airway diseases (AIRWAYS-ICPs)

D. Postma, I. Pavord, A. Sheikh, 2014, European Respiratory Journal.

Improving the Management of COPD in Women.

C. Jenkins, N. Roche, I. Tsiligianni, 2017, Chest.

Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis

C. Jenkins, A. Sunjaya, G. D. Di Tanna, 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

Effect on health‐related quality of life of ongoing feedback during a 12‐month maintenance walking programme in patients with COPD: a randomized controlled trial

C. Jenkins, J. Alison, Z. McKeough, 2018, Respirology.

Ground-based walking training improves quality of life and exercise capacity in COPD

C. Jenkins, J. Alison, Z. McKeough, 2014, European Respiratory Journal.

Bias due to withdrawal in long‐term randomised trials in COPD: Evidence from the TORCH study

P. Calverley, C. Jenkins, B. Celli, 2011, The clinical respiratory journal.

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

C. Jenkins, E. Bateman, P. O'Byrne, 2017, BMC Pulmonary Medicine.

A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma.

C. Jenkins, A. James, G. Marks, 2019, The Journal of allergy and clinical immunology.

Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

C. Jenkins, A. James, S. Wesselingh, 2018, The Journal of allergy and clinical immunology.

The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking.

C. Jenkins, J. Alison, Z. McKeough, 2019, Respiratory medicine.

Chronic obstructive pulmonary disease--a treatable disease.

C. Jenkins, J. Leuppi, M. Osthoff, 2013, Swiss medical weekly.

Methods for therapeutic trials in COPD: lessons from the TORCH trial

J A Anderson, P. Jones, P. Calverley, 2009, European Respiratory Journal.

Lung function decline in COPD trials

P. Jones, P. Calverley, C. Jenkins, 2009, European Respiratory Journal.

CLINICAL PRACTICE GUIDELINES Australian and New Zealand Pulmonary Rehabilitation Guidelines

Andrew, Regina, Mary, 2020 .

Physical activity patterns and clusters in 1001 patients with COPD

Oliver Amft, Kenneth Meijer, Dina Brooks, 2017, Chronic respiratory disease.

Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity

C. Jenkins, N. Hopkinson, L. Vanfleteren, 2021, Respirology.

Low leisure-based sitting time and being physically active were associated with reduced odds of death and diabetes in people with chronic obstructive pulmonary disease: a cohort study.

C. Jenkins, J. Alison, Z. McKeough, 2018, Journal of physiotherapy.

Effects of ground-based walking training on daily physical activity in people with COPD: A randomised controlled trial.

C. Jenkins, L. Straker, J. Alison, 2017, Respiratory medicine.

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

P. Calverley, C. Jenkins, B. Celli, 2011, European Respiratory Journal.

Increasing Walking Speed to Achieve a Pre-training Endurance Shuttle Walk Time of 5-10 min May Improve Test Responsiveness in People With Chronic Obstructive Pulmonary Disease

C. Jenkins, J. Alison, Z. McKeough, 2021, Journal of cardiopulmonary rehabilitation and prevention.

Respiratory Failure, Noninvasive Ventilation, and Symptom Burden: An Observational Study.

C. Jenkins, Tracy A. Smith, J. Ingham, 2019, Journal of pain and symptom management.

People With COPD Who Respond to Ground-Based Walking Training Are Characterized by Lower Pre-training Exercise Capacity and Better Lung Function and Have Greater Progression in Walking Training Distance

C. Jenkins, J. Alison, Z. McKeough, 2019, Journal of cardiopulmonary rehabilitation and prevention.

The burden of exacerbations in mild asthma: a systematic review

I. Pavord, C. Jenkins, P. O'Byrne, 2020, ERJ Open Research.

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

C. Jenkins, A. James, G. Marks, 2019, ERJ Open Research.

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

C. Jenkins, M. Hew, F. Thien, 2018, Respirology.

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.

C. Jenkins, B. Celli, J. Vestbo, 2009, Chest.

ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

C. Jenkins, B. Beghé, P. Williamson, 2021, European Respiratory Journal.

Real‐world study of acute exacerbations of COPD reveals real gaps in care

C. Jenkins, 2018, Respirology.

Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.

D. Postma, B. Make, C. Jenkins, 2013, Respiratory medicine.

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.

C. Jenkins, M. Hew, P. Reynolds, 2021, The journal of allergy and clinical immunology. In practice.

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease

D. Postma, B. Make, C. Jenkins, 2015, BMC Pulmonary Medicine.

Cardiovascular events in patients with COPD: TORCH Study results

C. Jenkins, B. Celli, J. Vestbo, 2010, Thorax.

Guidelines for the management of chronic obstructive pulmonary disease. Working Group of the South African Pulmonology Society.

C. Jenkins, L. Irving, C. Mitchell, 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The association of comorbid anxiety and depression with asthma‐related quality of life and symptom perception in adults

C. Jenkins, B. Toelle, T. Usherwood, 2008, Respirology.

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial

C. Jenkins, N. Zhong, B. Celli, 2022, International journal of chronic obstructive pulmonary disease.

Breathing Techniques for Asthma and Other Respiratory Diseases

C. Jenkins, 2012 .

Personalized treatment of asthma: the importance of sex and gender differences.

C. Jenkins, L. Boulet, K. Lavoie, 2022, The journal of allergy and clinical immunology. In practice.

Mepolizumab effectiveness and identification of super-responders in severe asthma

C. Jenkins, M. Hew, P. Reynolds, 2020, European Respiratory Journal.

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

P. Calverley, C. Jenkins, B. Celli, 2022, American journal of respiratory and critical care medicine.

ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial

C. Jenkins, A. Hayes, C. Chow, 2019, BMJ Open.

Starting beta‐blockers during exacerbations of chronic obstructive pulmonary disease

C. Jenkins, R. Hancox, R. Beasley, 2018, Internal medicine journal (Print).

Standardization of ambulatory peak flow monitoring: the importance of recent beta2-agonist inhalation.

C. Jenkins, C. Salome, G. Marks, 1998, The European respiratory journal.

Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist.

C. Jenkins, P. Gibson, C. Hoyos, 2010, Respiratory medicine.

Pitfalls in processing home electronic spirometric data in asthma.

C. Jenkins, C. Salome, A. Woolcock, 1998, The European respiratory journal.

Measuring asthma control: a comparison of three classification systems

C. Jenkins, E. Bateman, P. O'Byrne, 2010, European Respiratory Journal.

Effect of different asthma treatments on risk of cold-related exacerbations

C. Jenkins, E. Bateman, P. O'Byrne, 2011, European Respiratory Journal.

Traditional and patient-centred outcomes with three classes of asthma medication

C. Jenkins, J. Wheatley, F. Thien, 2005, European Respiratory Journal.

A mixed methods study of Aboriginal health workers’ and exercise physiologists’ experiences of co-designing chronic lung disease ‘yarning’ education resources

C. Jenkins, G. Maguire, J. Alison, 2023, BMC Public Health.

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

C. Jenkins, B. Beghé, P. Williamson, 2020, ERJ Open Research.

Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study

C. Jenkins, P. Kelly, T. Kotsimbos, 2013, PloS one.

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

D. Postma, I. Pavord, A. Sheikh, 2017, Clinical and Translational Allergy.

Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment

C. Jenkins, A. James, G. Marks, 2021, Allergy.

Questions in Mild Asthma: An Official American Thoracic Society Research Statement

B. Yawn, C. Jenkins, E. Israel, 2023, American journal of respiratory and critical care medicine.

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

C. Jenkins, W. Busse, Á. Cruz, 2016, European Respiratory Review.

Rationale for universal face masks in public against COVID‐19

C. Jenkins, A. Sunjaya, 2020, Respirology.

ASID/TSANZ guidelines: Treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents

C. Jenkins, T. Kotsimbos, A. Cheng, 2009 .

Diurnal variability—time to change asthma guidelines?

C. Jenkins, H. Reddel, H Reddel, 1999, BMJ.

Investigating asthma symptoms in primary care

C. Jenkins, L. Seccombe, R. Tomlins, 2012, BMJ : British Medical Journal.

Investigating asthma symptoms in primary care Even when dyspnoea is accompanied by a history of wheeze, use of spirometry and related tests is needed before making a diagnosis of asthma

C. Jenkins, R. Tomlins, 2012 .

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps

C. Jenkins, E. Bateman, P. O'Byrne, 2011, Respiratory research.

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients

C. Jenkins, T. Biering-Sørensen, J. Vestbo, 2023, Biomedicines.

AMERICAN THORACIC SOCIETY DOCUMENTS

B. Yawn, C. Jenkins, E. Israel, 2023 .

Feasibility study of a communication and education asthma intervention for general practitioners in Australia.

C. Jenkins, B. Toelle, T. Usherwood, 2010, Australian journal of primary health.

Predictors Of Asthma Control And A Risk Score For Exacerbations

C. Jenkins, E. Bateman, P. O'Byrne, 2012, ATS 2012.

COPD management. Part I. Strategies for managing the burden of established COPD.

C. Jenkins, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.

C. Jenkins, C. Salome, A. Woolcock, 2002, American journal of respiratory and critical care medicine.

A snapshot of general practitioner attitudes, levels of confidence and self-reported paediatric asthma management practice.

C. Jenkins, B. Toelle, T. Usherwood, 2011, Australian journal of primary health.

Analysis of adherence to peak flow monitoring when recording of data is electronic

C. Jenkins, A. Woolcock, B. Toelle, 2002, BMJ : British Medical Journal.

Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.

C. Jenkins, P. Kelly, H. Kelly, 2011, Vaccine.

Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial.

C. Jenkins, G. Marks, H. Reddel, 2008, Primary care respiratory journal : journal of the General Practice Airways Group.

The TORCH (TOwards a Revolution in COPD Health) survival study protocol

C. Jenkins, N. Pride, T. Similowski, 2004, European Respiratory Journal.

INVITED REVIEW SERIES: COPD: NEW HORIZONS SERIES EDITORS: CHRISTINE JENKINS AND PASCAL CHANEZ Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity

C. Jenkins, N. Hopkinson, L. Vanfleteren, 2021 .

‘You have to learn to live with it’: a qualitative and quantitative study of older people with asthma

C. Jenkins, J. Douglass, D. Goeman, 2007, The clinical respiratory journal.

Translation of an evidence-based asthma intervention: Physician Asthma Care Education (PACE) in the United States and Australia.

M. Cabana, C. Jenkins, Randall Brown, 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

C. Jenkins, A. James, G. Marks, 2019, ERJ Open Research.

Development and validation of the Patient Asthma Concerns Tool (PACT) to identify the needs of older people with asthma.

C. Jenkins, M. Crane, J. Douglass, 2012, Respiratory medicine.

Cardiovascular events in patients with COPD: TORCH Study results

C. Jenkins, B. Celli, J. Vestbo, 2010, Thorax.

Sputum and Serum Periostin Levels Are Associated With, But Do Not Predict Sputum Eosinophil Proportion in Severe Asthma

C. Jenkins, A. James, S. Hodge, 2015 .

Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial.

C. Jenkins, G. Marks, H. Reddel, 2008, Primary care respiratory journal : journal of the General Practice Airways Group.

Asthma in older adults: a holistic, person‐centred and problem‐oriented approach

C. Jenkins, G. Marks, P. Gibson, 2009, The Medical journal of Australia.

Improving general practice consultations for older people with asthma: a cluster randomised control trial

C. Jenkins, L. Sanci, J. Douglass, 2009, The Medical journal of Australia.